A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines (Q40299196)

19 September 2017

title

A West Nile virus CD4 T cell epitope improves the immunogenicity of dengue virus serotype 2 vaccines (English)

1 reference

19 September 2017

0 references

0 references

Holly R Hughes

1

1 reference

19 September 2017

Wayne D Crill

series ordinal

2

1 reference

19 September 2017

Brent S Davis

series ordinal

3

1 reference

19 September 2017

Gwong-Jen J Chang

series ordinal

4

1 reference

19 September 2017

language of work or name

English

0 references

publication date

14 January 2012

1 reference

19 September 2017

1 reference

19 September 2017

volume

424

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

129-137

1 reference

West Nile meningo-encephalitis infection in a kidney transplant recipient

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

West Nile Virus encephalopathy following pancreatic islet transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Analysis of total human immunodeficiency virus (HIV)-specific CD4( ) and CD8( ) T-cell responses: relationship to viral load in untreated HIV infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Protective capacity and epitope specificity of CD8( ) T cells responding to lethal West Nile virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Prospective immunization of the endangered California condors (Gymnogyps californianus) protects this species from lethal West Nile virus infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

HBsAg-vectored vaccines simultaneously deliver CTL responses to protective epitopes from multiple viral pathogens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Strategies for effective naked-DNA vaccination against infectious diseases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Humoral Immune Responses of Dengue Fever Patients Using Epitope-Specific Serotype-2 Virus-Like Particle Antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Glycoconjugate vaccines and immune interference: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

West Nile virus recombinant DNA vaccine protects mouse and horse from virus challenge and expresses in vitro a noninfectious recombinant antigen that can be used in enzyme-linked immunosorbent assays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Potent immunogenic short linear peptide constructs composed of B cell epitopes and Pan DR T helper epitopes (PADRE) for antibody responses in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

West Nile virus encephalitis in organ transplant recipients: another high-risk group for meningoencephalitis and death

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Characteristics of the rash associated with West Nile virus fever

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

CD40 AND CD154 IN CELL-MEDIATED IMMUNITY

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

The global emergence/resurgence of arboviral diseases as public health problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Evaluation of interferences between dengue vaccine serotypes in a monkey model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Mapping T cell epitopes by flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

DNA vaccines with single-chain Fv fused to fragment C of tetanus toxin induce protective immunity against lymphoma and myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Naturally acquired West Nile virus encephalomyelitis in transplant recipients: clinical, laboratory, diagnostic, and neuropathological features

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Community-acquired West Nile virus infection in solid-organ transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

DNA and RNA-based vaccines: principles, progress and prospects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Improved efficacy of DNA vaccination against prostate carcinoma by boosting with recombinant protein vaccine and by introduction of a novel adjuvant epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Use of overlapping peptide mixtures as antigens for cytokine flow cytometry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

A West Nile Virus DNA Vaccine Induces Neutralizing Antibody in Healthy Adults during a Phase 1 Clinical Trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Plasmid DNA: a new era in vaccinology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Genetic immunization is a simple method for eliciting an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Insights into HLA-restricted T cell responses in a novel mouse model of dengue virus infection point toward new implications for vaccine design

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Trivalent Human Papillomavirus (HPV) VLP vaccine covering HPV type 58 can elicit high level of humoral immunity but also induce immune interference among component types.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

A DNA fusion vaccine induces bactericidal antibodies to a peptide epitope from the PorA porin of Neisseria meningitidis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

Multiple specificities in the murine CD4 and CD8 T-cell response to dengue virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak

1 reference

https://api.crossref.org/works/10.1016/J.VIROL.2011.12.012

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2011.12.012

1 reference

release_qoybx7ipnzdmpjzjjr7wn4yi3q

19 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qoybx7ipnzdmpjzjjr7wn4yi3q

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference